Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DARH: Hydroxyurea PK in Sickle Cell Disease
NCT02522104Phase 4Completed
- Sponsor
- Theravia
- Start
- Sep 2015
- Primary completion
- Nov 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of hydroxyurea in sickle cell disease (SCD), sponsored by Theravia. Started Sep 2015; status: completed.
02
Drugs
hydroxyurea
03
Conditions
sickle cell disease (SCD)
Beyond the preview
Go deeper on NCT02522104.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02522104.